Psychopharmacologic
Drugs Advisory Committee Meeting
March 23,
2006
TABLE OF CONTENTS
Tab 1: FDA
Cover Memo - Laughren
Tab 2: FDA
Clinical Review - Mannheim
Tab 3: FDA
Statistical Review - Massie
Tab 4: FDA
Approvable Letter - Andreason
Tab 5: FDA
Approvable Letter - Laughren
Tab 7: FDA
Dermatology Consult - Luke
Tab 8: FDA
Dermatology Consult - Porres
Tab 9: Sponsor’s
Proposed Label